EDGAR Filing Documents for 0001193125-09-194777

Form 8-K - Current report:

SEC Accession No. 0001193125-09-194777

Filing Date

2009-09-21

Accepted

2009-09-21 09:00:48

Documents

Period of Report

2009-09-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	43982
2	ASSET CONTRIBUTION AGREEMENT - PERSEID THERAPEUTICS LLC	dex211.htm	EX-2.1.1	265017
3	TECHNOLOGY LICENSE AGREEMENT - PERSEID THERAPEUTICS LLC	dex212.htm	EX-2.1.2	224949
4	LIMITED LIABILITY COMPANY AGREEMENT OF PERSEID THERAPEUTICS LLC	dex213.htm	EX-2.1.3	255201
5	SERIES A AND SERIES B PREFERRED UNIT PURCHASE AGREEMENT	dex214.htm	EX-2.1.4	77982
6	INVESTORS' RIGHTS AGREEMENT	dex215.htm	EX-2.1.5	169029
7	CO-SALE AGREEMENT - PERSEID THERAPEUTICS LLC, MAXYGEN, INC. AND ASTELLAS BIO INC	dex216.htm	EX-2.1.6	82519
8	VOTING AGREEMENT - PERSEID THERAPEUTICS LLC, MAXYGEN, INC. AND ASTELLAS BIO INC	dex217.htm	EX-2.1.7	64195
9	PERSEID THERAPEUTICS LLC 2009 EQUITY INCENTIVE PLAN	dex105.htm	EX-10.5	88427
10	PRESS RELEASE	dex991.htm	EX-99.1	11723
11	GRAPHIC	g29834g93q99.jpg	GRAPHIC	13515
	Complete submission text file	0001193125-09-194777.txt		1303505

Mailing Address 515 GALVESTON DRIVE REDWOOD CITY CA 94063

Business Address 515 GALVESTON DRIVE REDWOOD CITY CA 94063 6502985300

MAXYGEN INC (Filer) CIK: 0001068796 (see all company filings)